发明名称 Method and apparatus for treatment of pathogens including viruses and bacteria
摘要 A method for disrupting or destroying selected pathogens located within the body of an organism the method including the non-invasive administration to pre-selected locations on or in the organism of an amount of low intensity ultrasonic energy, effective to disrupt or destroy the selected pathogens but not deleteriously affect the organism, the low intensity ultrasonic energy falling within predefined ranges of frequencies, wherein the predefined range of frequencies is one or more ranges of frequencies at which the low intensity ultrasonic energy has optimal effectiveness in disrupting or destroying a particular pathogen, and the intensity of the low intensity ultrasonic energy falling within predefined ranges of intensity, wherein the predefined range of intensity of low intensity ultrasonic energy is such as to allow for disruption or destruction of the selected pathogens but not deleteriously affect tissue of the organism surrounding the selected pathogens.
申请公布号 US9079009(B2) 申请公布日期 2015.07.14
申请号 US201214237530 申请日期 2012.08.08
申请人 发明人 Csizmadia Paul
分类号 A61H1/00;A61N7/00;A61H23/02;A61H33/00 主分类号 A61H1/00
代理机构 Brooks Kushman P.C. 代理人 Brooks Kushman P.C.
主权项 1. A method for disrupting or destroying selected pathogens selected from the group comprising Herpes Simplex virus I, Herpes Simplex virus II, and Staphylococcus Aureus located within the body of an organism including the steps of: selecting a pathogen to be disrupted, with each pathogen being subjected to intensity of a low intensity ultrasonic energy to a value distribution substantially limited within predefined ranges of frequencies, wherein the predefined ranges of frequencies are: 291 to 293 kHz and 345 to 346 kHz, where a selected pathogen is Herpes Simplex virus I; 353 to 354 kHz and 362 to 363 kHz, where a selected pathogen is Herpes Simplex virus II; and 376 to 377 kHz and 380 to 381 kHz, where a selected pathogen is Staphylococcus Aureus, non-invasively administering an amount of the low intensity ultrasonic energy to a treatment location on or in the organism, wherein the treatment location is a ganglia, where the selected pathogen is Herpes Simplex viruses I or II or a site of infection, where the selected pathogen is Staphylococcus Aureus, and disrupting or destroying the selected pathogen while not deleteriously affecting the organism.
地址